Cargando…
Isolation and Characterization of the Novel Bacteriophage AXL3 against Stenotrophomonas maltophilia
The rapid increase in the number of worldwide human infections caused by the extremely antibiotic resistant bacterial pathogen Stenotrophomonas maltophilia is cause for concern. An alternative treatment solution in the post-antibiotic era is phage therapy, the use of bacteriophages to selectively ki...
Autores principales: | McCutcheon, Jaclyn G., Lin, Andrea, Dennis, Jonathan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504290/ https://www.ncbi.nlm.nih.gov/pubmed/32882851 http://dx.doi.org/10.3390/ijms21176338 |
Ejemplares similares
-
Characterization of Stenotrophomonas maltophilia phage AXL1 as a member of the genus Pamexvirus encoding resistance to trimethoprim–sulfamethoxazole
por: McCutcheon, Jaclyn G., et al.
Publicado: (2022) -
Characterization of Novel Broad-Host-Range Bacteriophage DLP3 Specific to Stenotrophomonas maltophilia as a Potential Therapeutic Agent
por: Peters, Danielle L., et al.
Publicado: (2020) -
The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia
por: McCutcheon, Jaclyn G., et al.
Publicado: (2021) -
Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range Stenotrophomonas maltophilia Bacteriophages DLP1 and DLP2
por: McCutcheon, Jaclyn G., et al.
Publicado: (2018) -
Novel Stenotrophomonas maltophilia temperate phage DLP4 is capable of lysogenic conversion
por: Peters, Danielle L., et al.
Publicado: (2019)